Novel endoscopic visualization techniques for bladder cancer detection: A review of the contemporary literature

Current Opinion in Urology

Volumn 28, Issue 2, 2018, Pages 214-218

  Mari, Andrea ^a   Abufaraj, Mohammad ^a,b   Gust, Killian M ^a   Shariat, Shahrokh F ^a,c,d,e,f  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b JORDAN UNIVERSITY HOSPITAL   (Jordan)

^c KARL LANDSTEINER INSTITUTE OF UROLOGY AND ANDROLOGY   (Austria)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

narrow band imaging; nonmuscle invasive bladder cancer; photodynamic diagnosis; Storz Professional Image Enhancement System; transurethral resection of bladder tumor

Indexed keywords

BLADDER CANCER; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CARCINOMA IN SITU; CLINICAL PRACTICE; CYSTOSCOPY; DIAGNOSTIC PROCEDURE; HUMAN; IMAGE ENHANCEMENT; NARROW BAND IMAGING; PHOTODYNAMIC DIAGNOSIS; PHOTODYNAMICS; PRIORITY JOURNAL; PROFESSIONAL IMAGE; PROGRESSION FREE SURVIVAL; RECURRENCE RISK; REVIEW; STORZ PROFESSIONAL IMAGE ENHANCEMENT SYSTEM; BLADDER; BLADDER TUMOR; DEVICES; DIAGNOSTIC IMAGING; EVALUATION STUDY; INTRAVESICAL DRUG ADMINISTRATION; PROCEDURES; SENSITIVITY AND SPECIFICITY; SOFTWARE; TRENDS;

PHOTOSENSITIZING AGENT;

ADMINISTRATION, INTRAVESICAL; CYSTOSCOPY; HUMANS; IMAGE ENHANCEMENT; NARROW BAND IMAGING; PHOTOSENSITIZING AGENTS; SENSITIVITY AND SPECIFICITY; SOFTWARE; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 85042416553     PISSN: 09630643     EISSN: 14736586     Source Type: Journal    
DOI: 10.1097/MOU.0000000000000459     Document Type: Review

References (34)

1. Fitzmaurice C, Allen C, Barber RM, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disabilityadjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the Global Burden of Disease Study. JAMA Oncol 2017; 3:524-548.
2. Sauter G. Tumours of the urinary system: noninvasive urothelial neoplasias. WHO classification of tumours of the urinary system and male genital organs. 2004.
3. Allard P, Bernard P, Fradet Y, Tetu B. The early clinical course of primary Ta and T1 bladder cancer: A proposed prognostic index. Br J Urol 1998; 81:692-698.
4. Kurth KH, Denis L, Bouffioux C, et al. Factors affecting recurrence and progression in superficial bladder tumours. Eur J Cancer 1995; 31A: 1840-1846.
5. Jichlinski P, Leisinger H-J. Fluorescence cystoscopy in the management of bladder cancer: A help for the urologist! Urol Int 2005; 74:97-101.
6. Whitmore WFJ, Bush IM, Esquivel E. Tetracycline ultraviolet fluorescence in bladder carcinoma. Cancer 1964; 17:1528-1532.
7. Kriegmair M, Baumgartner R, Knuechel R, et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-Aminolevulinic acid. Urology 1994; 44:836-841.
8. Bryan RT, Billingham LJ, Wallace DMA. Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder. BJU Int 2008; 101:702-706.
9. Emiliani E, Talso M, Baghdadi M, et al. Evaluation of the SpiesTM modalities image quality. Int Braz J Urol 2017; 43:476-480.
10. Marti A, Lange N, van den Bergh H, et al. Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: An in vitro approach. J Urol 1999; 162:546-552.
11. Lane GI, Downs TM, Soubra A, et al. Tolerability of repeat use of blue light cystoscopy with hexaminolevulinate for patients with urothelial cell carcinoma. J Urol 2017; 197:596-601.
12. Rink M, Babjuk M, Catto JWF, et al. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with nonmuscleinvasive bladder cancer: A critical review of the current literature. Eur Urol 2013; 64:624-638.
13. Burger M, Grossman HB, Droller M, et al. Photodynamic diagnosis of nonmuscle-invasive bladder cancer with hexaminolevulinate cystoscopy: A meta-Analysis of detection and recurrence based on raw data. Eur Urol 2013; 64:846-854.
14. Lee JY, Cho KS, Kang DH, et al. A network meta-Analysis of therapeutic outcomes after new image technology-Assisted transurethral resection for nonmuscle invasive bladder cancer: 5-Aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging. BMC Cancer 2015; 15:566.
15. Gakis G, Fahmy O. Systematic review and meta-Analysis on the impact of hexaminolevulinate-versus white-light guided transurethral bladder tumor resection on progression in non-muscle invasive bladder cancer. Bladder Cancer 2016; 2:293-300.
16. Grossman HB, Stenzl A, Fradet Y, et al. Long-Term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy. J Urol 2012; 188:58-62.
17. Kamat AM, Cookson M, Witjes JA, et al. The impact of blue light cystoscopy with hexaminolevulinate (HAL) on progression of bladder cancer-A new analysis. Bladder Cancer 2016; 2:273-278.
18. Lamm D, Persad R, Brausi M, et al. Defining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definition. J Urol 2014; 191:20-27.
19. Gakis G, Ngamsri T, Rausch S, et al. Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy. World J Urol 2015; 33:1429-1437.
20. MayM, Fritsche H-M, Vetterlein MW, et al. Impact of photodynamic diagnosisassisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS. World J Urol 2017; 35:293-300.
21. Bryan RT, Shah ZH, Collins SI, Wallace DMA. Narrow-band imaging flexible cystoscopy: A new users experience. J Endourol 2010; 24:1339-1343.
22. Herr H, Donat M, Dalbagni G, Taylor J. Narrow-band imaging cystoscopy to evaluate bladder tumours-individual surgeon variability. BJU Int 2010; 106:53-55.
23. Cauberg ECC, Kloen S, Visser M, et al. Narrow band imaging cystoscopy improves the detection of nonmuscle-invasive bladder cancer. Urology 2010; 76:658-663.
24. Tatsugami K, Kuroiwa K, Kamoto T, et al. Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer. J Endourol 2010; 24:1807-1811.
25. Xiong Y, Li J, Ma S, et al. A meta-Analysis of narrow band imaging for the diagnosis and therapeutic outcome of nonmuscle invasive bladder cancer. PLoS One 2017; 12:e0170819.
26. Kang W, Cui Z, Chen Q, et al. Narrow band imaging-Assisted transurethral resection reduces the recurrence risk of nonmuscle invasive bladder cancer: A systematic review and meta-Analysis. Oncotarget 2017; 8:23880-23890.
27. Naito S, Algaba F, Babjuk M, et al. The Clinical Research Office of the Endourological Society (CROES) multicentre randomised trial of narrow band imaging-Assisted transurethral resection of bladder tumour (TURBT) versus conventional white light imaging-Assisted TURBT in primary non-muscleinvasive bladder cancer patients: Trial protocol and 1-year results. Eur Urol 2016; 70:506-515.
28. Bach T, Muschter R, Herrmann TRW, et al. Technical solutions to improve the management of nonmuscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future pers. BJU Int 2015; 115:14-23.
29. Kamphuis GM, de Bruin DM, Brandt MJ, et al. Comparing image perception of bladder tumors in four different storz professional image enhancement system modalities using the iSPIES app. J Endourol 2016; 30:602-608.
30. Gravas S, Stenzl A. The Storz Professional Image Enhancement System (SPIES) nonmuscle-invasive bladder cancer study: A multicenter international randomized controlled study. J Endourol 2014; 28:1254-1255.
31. Babjuk M, Bohle A, Burger M, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update. Eur Urol 2017; 71:447-461.
32. Hall MC, Chang SS, Dalbagni G, et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 2007; 178:2314-2330.
33. Zheng C, Lv Y, Zhong Q, et al. Narrow band imaging diagnosis of bladder cancer: systematic review and meta-Analysis. BJU Int 2012; 110: E680-E687.
34. Herr HW. Randomized trial of narrow-band versus white-light cystoscopy for restaging (second-look) transurethral resection of bladder tumors. Eur Urol 2015; 67:605-608.